image_alt_text
2

Samuel Wickline, MD

AIMBE College of Fellows Class of 2019
For pioneering advancements in molecular imaging with ultrasound and MRI/MRS, and biocompatible nanotechnologies targeting myriad diseases.

Silencing RNA nanotherapy shows promise against pancreatic cancer

Via EurekAlert | October 21, 2019

Despite advances in cancer survival, more than 90 percent of people with pancreatic cancer die within five years. Most patients with pancreatic tumors (and half of those with colorectal cancers) carry a mutation in the KRAS gene, which normally controls cell growth and death.

The KRAS oncogene was discovered more than 35 years ago and is considered one of the most desirable targets in cancer biology — particularly for cancers (like pancreatic) often diagnosed late and in desperate need of improved therapies to prolong survival. Yet KRAS has earned a reputation as being “undruggable” by researchers who continue searching for effective ways to inhibit the mutated form of RAS proteins driving the growth of deadly tumors… Continue reading.

...

Dr. Samuel Wickline Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 28, 2019

WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Samuel Wickline, MD, Professor and Chairman, Department of Cardiovascular Sciences; Professor, Molecular Pharmacology, Morsani College of Medicine, University of South Florida, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Wickline was nominated, reviewed, and elected by peers and members of the College of Fellows for “pioneering advancements in molecular imaging with ultrasound and MRI/MRS, and biocompatible nanotechnologies targeting myriad diseases.”

...